Skip to product information

The MD Anderson Cancer Center A Comprehensive Board Review in Hematology and Medical Oncology 2025

The MD Anderson Cancer Center A Comprehensive Board Review in Hematology and Medical Oncology 2025

Regular price $100.00 USD
Regular price $100.00 USD Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
The MD Anderson Cancer Center A Comprehensive Board Review in Hematology and Medical Oncology 2025

The MD Anderson Cancer Center A Comprehensive Board Review in Hematology and Medical Oncology 2025

Regular price $100.00
Regular price $100.00 Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
    View full details

    The MD Anderson Cancer Center A Comprehensive Board Review in Hematology and Medical Oncology 2025

    86 Videos +113 PDFs
    Target Audience: hematology/oncology physicians, fellows and practicing internists

     

     Information:


    Date & Location: Monday, September 15, 2025, 7:00 AM – Saturday, September 20, 2025, 5:30 PM, MD Anderson – Virtual

    Target Audience:
    Specialties – Colon and Rectal Surgery, Gynecologic Oncology, Hematology, Medical Oncology, Neurological Surgery, Obstetrics and Gynecology, Thoracic Surgery, Urology
    Professions – Nurse – APRN, Nurse – LVN, Nurse – RN, Pharmacist, Pharmacy Technician, Physician (MD or DO), Student or Trainee
    Overview

    The course is a 6-day comprehensive review of current standards and practices in the management of patients with blood disorders and malignancy. The course is designed to enable the participant to effectively prepare for the American Board of Internal Medicine certification and recertification examinations in Hematology and Medical Oncology. Advances in clinical pharmacology, molecular genetics and risk assessment, and radiation oncology will be included.
    Objectives
    At the conclusion of this activity, learners will be able to:
    1. Apply knowledge gained to prepare for the hematology and medical oncology subspecialty and recertification examinations in hematology and medical oncology.
    2. Utilize current standards of care for patients with cancer, blood disorders and malignancies.
    3. Demonstrate proficiency of knowledge in hematology and medical oncology.
    4. Incorporate recent advances in management of hematologic and oncologic patients.

     

    Topics:
    Schedule